Rezolute, Inc.

RZLT chart

Rezolute, Inc. news

• Rezolute at Guggenheim: FDA progress lifts rare-disease hopes By Investing.com

  Investing.com UK · Nov 9, 9:34 AM EST

• Weekly Recap: 2027 ersodetug filing plan and Q1 loss, 12-month runway

  TradingView · Nov 9, 6:00 AM EST

• Rezolute, Inc. (RZLT) Seasonal returns chart

  Yahoo Finance UK · Nov 7, 5:35 PM EST

• Rezolute, Inc. (RZLT) Stock Price, News, Quote & History

  Yahoo! Finance Canada · Nov 6, 12:02 AM EST

• Form S-3 Rezolute Inc For: 5 November By Investing.com

  Investing.com Nigeria · Nov 5, 11:47 PM EST

• Rezolute Q1 loss widens slightly; sees Phase 3 tumor HI data by mid-Dec 2026

  TradingView · Nov 5, 5:08 PM EST

• Rezolute 3Q 2026: EPS ($0.18) — 10-Q Summary

  TradingView · Nov 5, 4:35 PM EST

• Rezolute, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2026

  www.marketscreener.com · Nov 5, 4:25 PM EST

• Rezolute Reports First Quarter Fiscal 2027 Financial Results and Provides Business Update

  Yahoo Finance · Nov 5, 4:05 PM EST

• Rezolute Inc. (6HV1.SG) options chain

  Yahoo Finance UK · Nov 4, 11:12 AM EST

• Rezolute to Participate in Upcoming Investor Conferences

  Yahoo Finance · Nov 2, 7:30 AM EST

• Rezolute Announces Completion of Enrollment in Phase 3 upLIFT Study of Ersodetug in Tumor Hyperinsulinism

  Yahoo Finance · Oct 14, 4:05 PM EDT

Rezolute, Inc. key financials

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 10-Q10-Q2026-11-05
• 8-KFORM 8-K2026-11-05
• 8-KFORM 8-K2026-10-29
• DEF 14ADEF 14A2026-10-21
• 8-KFORM 8-K2026-10-14
• 8-KFORM 8-K2026-10-05
• 10-K10-K2026-09-24
• 8-KFORM 8-K2026-09-24
• 8-KFORM 8-K2026-06-02
• 10-Q10-Q2026-05-12
• 8-KFORM 8-K2026-05-12
• 8-KFORM 8-K2026-05-04

About Rezolute, Inc.

Ticker

RZLT (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

Redwood City, CA

Incorporated in

NV

Fiscal year end

June 30

SEC CIK

1509261

Former names

AntriaBio, Inc., FITS MY STYLE INC

Frequently asked questions